Dr. Bita Esmaeli, MD

Dr. Esmaeli practices at Houston Methodist Hospital in Houston, Texas, part of Houston Methodist.

Dr. Esmaeli's NPI, 1306930482, was assigned on October 3, 2006. Dr. Esmaeli graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1990. Dr. Esmaeli's Texas license number on file is K6579.

Dr. Esmaeli's primary practice is Houston Methodist Hospital, at 6565 Fannin, Houston, TX 77030 in Harris County. The practice phone is (713) 790-2221.

Dr. Esmaeli's primary practice is Houston Methodist Hospital in Houston, Texas, part of Houston Methodist. The medical group on file is Texas Surgical Dermatology. Dmand AI also links Dr. Esmaeli to 2 more group practices and clinics, 2 medical groups and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Esmaeli practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Esmaeli's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Esmaeli is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Esmaeli's licenses on file in 13 states: Texas, Florida, California, Ohio, Arizona, Georgia, Louisiana, Mississippi, Oklahoma, Tennessee, Washington, Alabama and Michigan.

Dmand AI lists dry eye, eye infection or inflammation, eyelid inflammation and visual impairment and blindness among the conditions Dr. Esmaeli treats.

CMS data shows 136 Medicare services from Dr. Esmaeli across 4 procedure codes in 2024, all of them office visits, for 137 Medicare patients. Medicare paid $9,237 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 137 Medicare patients who saw Dr. Esmaeli in 2024. The largest group is 65 to 74, with 66 patients. 74% of them have high blood pressure, and 74% have high cholesterol. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Esmaeli's median patient age at 70, with 58% women.

In 2024, Dr. Esmaeli wrote 104 Medicare Part D claims for 44 patients. 99% of them were for generic drugs. CMS names the drug for 99 of them, across 4 drugs with 11 or more claims each, at $1,687 in total drug cost. In 2023, CMS named 112 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Esmaeli for performance year 2024, reported as part of a group. Dr. Esmaeli accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 220 papers to Dr. Esmaeli, published from 2005 to 2025. 2021 was the busiest year, with 10. The most frequent topics are Eyelid Neoplasms, Orbital Neoplasms and Melanoma. Dr. Esmaeli has published most often in Ophthalmic Plast Reconstr Surg. Dr. Esmaeli's most frequent co-authors are James M. Debnam, MD, Victor G. Prieto, MD, PhD and Steven J. Frank, MD.

Dmand AI links Dr. Esmaeli to 4 clinical trials. Conditions studied include Facies, Melanoma and Orbital lymphoma. M.D. Anderson Cancer Center sponsors the most, 4.

CMS Open Payments shows 8 general payments to Dr. Esmaeli from 5 drug and device companies from 2017 to 2023. Consulting fees make up the largest share, 93% of the total. Genentech, Inc. paid the most, $4,660.

Dmand AI lists 7 awards for Dr. Esmaeli.

Dr. Esmaeli graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1990. Dr. Esmaeli is a member of AAO and ACS.

Dr. Esmaeli is in network with 13 carriers, including Elevance, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.